Matches in Nanopublications for { ?s ?p "[A significant decrease of SOD (P < 0.05), GPX (P < 0.05) and nonsignificant decrease of CAT (P > 0.05), and TAS status (P > 0.05) were seen in T2DM patients with neuropathy compared to T2DM patients as well as controls.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP620311.RAAb0eLyE9kr0UwsJRw7RKWd05ZrvxK8rTveySs41mSQs130_assertion description "[A significant decrease of SOD (P < 0.05), GPX (P < 0.05) and nonsignificant decrease of CAT (P > 0.05), and TAS status (P > 0.05) were seen in T2DM patients with neuropathy compared to T2DM patients as well as controls.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP620311.RAAb0eLyE9kr0UwsJRw7RKWd05ZrvxK8rTveySs41mSQs130_provenance.
- NP230046.RASPG516SDRGGslZp8AS9D8fCLD7YZC38zbd66taOK26A130_assertion description "[A significant decrease of SOD (P < 0.05), GPX (P < 0.05) and nonsignificant decrease of CAT (P > 0.05), and TAS status (P > 0.05) were seen in T2DM patients with neuropathy compared to T2DM patients as well as controls.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP230046.RASPG516SDRGGslZp8AS9D8fCLD7YZC38zbd66taOK26A130_provenance.
- NP332878.RAA9jQn0nXjkr2VPkcGO85Te7S50ZwwcxCbfNxYIu5Bn4130_assertion description "[A significant decrease of SOD (P < 0.05), GPX (P < 0.05) and nonsignificant decrease of CAT (P > 0.05), and TAS status (P > 0.05) were seen in T2DM patients with neuropathy compared to T2DM patients as well as controls.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP332878.RAA9jQn0nXjkr2VPkcGO85Te7S50ZwwcxCbfNxYIu5Bn4130_provenance.
- NP717731.RAg7aPVeLdKKwsb5ZM4R0jX811wnq_7DA2c1vTt5DARzY130_assertion description "[A significant decrease of SOD (P < 0.05), GPX (P < 0.05) and nonsignificant decrease of CAT (P > 0.05), and TAS status (P > 0.05) were seen in T2DM patients with neuropathy compared to T2DM patients as well as controls.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP717731.RAg7aPVeLdKKwsb5ZM4R0jX811wnq_7DA2c1vTt5DARzY130_provenance.
- NP603822.RARoCQNrJSPbF58Wma9AriVuBzPFujTyxIk_gDGLDcJ7g130_assertion description "[A significant decrease of SOD (P < 0.05), GPX (P < 0.05) and nonsignificant decrease of CAT (P > 0.05), and TAS status (P > 0.05) were seen in T2DM patients with neuropathy compared to T2DM patients as well as controls.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP603822.RARoCQNrJSPbF58Wma9AriVuBzPFujTyxIk_gDGLDcJ7g130_provenance.
- NP696494.RAa7moBFsxPBV3twaOKcuRJGjHN2JeAUoZ2xOYzTt4XKA130_assertion description "[A significant decrease of SOD (P < 0.05), GPX (P < 0.05) and nonsignificant decrease of CAT (P > 0.05), and TAS status (P > 0.05) were seen in T2DM patients with neuropathy compared to T2DM patients as well as controls.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP696494.RAa7moBFsxPBV3twaOKcuRJGjHN2JeAUoZ2xOYzTt4XKA130_provenance.
- NP318294.RAGkHY5zYFNJITZNMYYrXuaKmAyD5olJ5IxH8-wHFJAaU130_assertion description "[A significant decrease of SOD (P < 0.05), GPX (P < 0.05) and nonsignificant decrease of CAT (P > 0.05), and TAS status (P > 0.05) were seen in T2DM patients with neuropathy compared to T2DM patients as well as controls.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP318294.RAGkHY5zYFNJITZNMYYrXuaKmAyD5olJ5IxH8-wHFJAaU130_provenance.
- NP737887.RA3dJci5mk-Xu5zLVrWrlgXiwIDTIDCPSOzPM07KC74os130_assertion description "[A significant decrease of SOD (P < 0.05), GPX (P < 0.05) and nonsignificant decrease of CAT (P > 0.05), and TAS status (P > 0.05) were seen in T2DM patients with neuropathy compared to T2DM patients as well as controls.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP737887.RA3dJci5mk-Xu5zLVrWrlgXiwIDTIDCPSOzPM07KC74os130_provenance.